These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
424 related items for PubMed ID: 29669501
1. Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease. Rukmangathen R, Yallamalli IM, Yalavarthi PR. Curr Drug Discov Technol; 2019; 16(4):417-425. PubMed ID: 29669501 [Abstract] [Full Text] [Related]
2. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery. Rukmangathen R, Yallamalli IM, Yalavarthi PR. Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571 [Abstract] [Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of intranasally administered selegiline nanoparticles with improved brain delivery in Parkinson's disease. Sridhar V, Gaud R, Bajaj A, Wairkar S. Nanomedicine; 2018 Nov; 14(8):2609-2618. PubMed ID: 30171904 [Abstract] [Full Text] [Related]
9. Pharmacological evaluation of nasal delivery of selegiline hydrochloride-loaded thiolated chitosan nanoparticles for the treatment of depression. Singh D, Rashid M, Hallan SS, Mehra NK, Prakash A, Mishra N. Artif Cells Nanomed Biotechnol; 2016 May; 44(3):865-77. PubMed ID: 26042481 [Abstract] [Full Text] [Related]
10. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP, Jain K, Jain NK. Int J Pharm; 2013 Nov 01; 456(1):31-40. PubMed ID: 23994363 [Abstract] [Full Text] [Related]
16. Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease. Bhattamisra SK, Shak AT, Xi LW, Safian NH, Choudhury H, Lim WM, Shahzad N, Alhakamy NA, Anwer MK, Radhakrishnan AK, Md S. Int J Pharm; 2020 Apr 15; 579():119148. PubMed ID: 32084576 [Abstract] [Full Text] [Related]